Health sector stocks dead last after first-quarter wraps up; But some say outlook rosy due to strong fundamentals, unlikely changes to Obamacare.

“It’s all in how you look at it,” I was taught as a child by my immigrant grandparents. What does this have to do with evaluating the healthcare sector’s first-quarter… Read more »

Gut-check alert: Don’t take your microbiome for granted. Seriously! And some gut-wrenching stock picks.

The News: Last month it was quietly reported that scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s… Read more »

Healthcare stocks display their resilience after bear market struck in December; well, most do.

The News: We’re hardly in a recession, and most forms of healthcare spending remain incredibly robust, regardless of what the overall economy does and what the White House says about… Read more »

Healthcare IPO dreamers not ready to throw in the towel despite recent market slump. Will 2019 stack up to 2018?

It’s now Daylight Saving Time and the question on the heretofore gloomy minds of a lot of us healthcare stock editorialists is: Will it be boom or kaboom for IPOs… Read more »

Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”

The News: Voyager Therapeutics Inc. (Cambridge MA) struck a deal with AbbVie Inc. (North Chicago) to develop and commercialize vectorized antibodies directed at pathological species of alpha-synuclein for the potential treatment of Parkinson’s… Read more »